Purple Biotech Ltd.
Develops cancer therapies to overcome tumor immune evasion and drug resistance.
PPBT | TA
Overview
Corporate Details
- ISIN(s):
- IL0007650166
- LEI:
- Country:
- Israel
- Address:
- Oppenheimer 4, 7670104 Rehovot
- Website:
- https://purple-biotech.com/
- Sector:
- Manufacturing
Description
Purple Biotech Ltd. is a clinical-stage company that develops first-in-class therapies for cancer patients. The company focuses on advancing treatments designed to overcome tumor immune evasion and drug resistance, with the goal of providing effective and durable therapeutic solutions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-05-07 01:45 |
6K: Purple Biotech Corporate Presentation May 2025
|
English | 36.6 KB | ||
| 2025-05-04 00:11 |
6K: Purple Biotech Reports Final Data from Phase 2 Study of CM24 in Pancreatic …
|
English | 205.5 KB | ||
| 2025-05-04 00:11 |
6K: Purple Biotech Reports Final Data from Phase 2 Study of CM24 in Pancreatic …
|
English | 36.8 KB | ||
| 2025-04-28 18:49 |
6K:Purple Biotech Reports Positive NT219 Data at AACR for Colorectal and Head a…
|
English | 200.1 KB | ||
| 2025-04-28 18:49 |
6K:Purple Biotech Reports Positive NT219 Data at AACR for Colorectal and Head a…
|
English | 36.6 KB | ||
| 2025-04-23 02:19 |
6K:Purple Biotech announcing the results of the Annual General Meeting of Share…
|
English | 125.4 KB | ||
| 2025-04-23 02:19 |
6K:Purple Biotech announcing the results of the Annual General Meeting of Share…
|
English | 36.7 KB | ||
| 2025-04-16 16:11 |
Publication in the Neuro Oncology Journal Demonstrating the Potential of NT219 …
|
English | 201.1 KB | ||
| 2025-04-16 16:11 |
Publication in the Neuro Oncology Journal Demonstrating the Potential of NT219 …
|
English | 36.7 KB | ||
| 2025-04-16 01:33 |
Annual General Meeting will be held on the day Tuesday on the date : 22/04/2025…
|
English | 83.7 KB | ||
| 2025-04-16 01:33 |
Annual General Meeting will be held on the day Tuesday on the date : 22/04/2025…
|
English | 524.3 KB | ||
| 2025-04-16 01:33 |
Annual General Meeting will be held on the day Tuesday on the date : 22/04/2025…
|
English | 121.1 KB | ||
| 2025-04-16 01:21 |
6K:the Company’s Annual Meeting of Shareholders held on Tuesday, April 15, 2025…
|
English | 127.5 KB | ||
| 2025-04-16 01:21 |
6K:the Company’s Annual Meeting of Shareholders held on Tuesday, April 15, 2025…
|
English | 36.8 KB | ||
| 2025-04-01 16:14 |
o Participate in Panel Discussion at Canaccord Genuity Horizons in Oncology Vir…
|
English | 162.9 KB |
Automate Your Workflow. Get a real-time feed of all Purple Biotech Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Purple Biotech Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Purple Biotech Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
